west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "卒中" 337 results
  • Stem Cell Transplantation for Stroke: A Systematic Review

    Objective To assess systematically the safety and ef fects of stem cell transplantation in stroke patients.Methods CENTRAL (April 2007), MEDLINE (1966 to April 2007), EMBASE (1980 to April 2007), and other databases were searched for RCT of the use of stem cell transplantation for patients with stroke. We critically appraised the quality of included studies according to Juny 2001. We assessed the effects of stem cell therapy on mortal ity, functional outcomes, cognitive functions, image changes, quality of life, and adverse effects by doing meta-analysis with The Cochrane Collaboration’ s Review Manager. Dichotomous outcomes were reported as relative risk and continuous outcome measures as weighted mean differences, with 95% confidence intervals.Results Three RCTs and one historical controlled trial were included involving a total of 69 participants. Only one trial reported the effect on mortality, but because of the small number of death it was not possible to detect any significant differences between stem cell transplantation and routine treatment (RR 0.11, 95%CI 0.01 to 2.31, P = 0.16). Three studies indicated a statistically significant improvement of some functional outcomes in patients treated by stem cell transplantation. Improvements of cognitive function were reported in another trial. One trial showed that the stem cell transplantation significantly improved qual ity of life compared with the control group. Conclusion The current evidence is insufficient to determine whether or not stem cell transplantation is a safe and effective therapy for stroke patients. High-quality, large-scale randomized trials are needed to assess the role of stem cell transplantation for stroke.

    Release date:2016-09-07 02:14 Export PDF Favorites Scan
  • Effect of the Electromyographic Biofeedback Therapy on the Extension of Wrist Joint of the Hemiplegic Patients after Stroke

    【摘要】 目的 探讨肌电生物反馈治疗对脑卒中偏瘫患肢上肢腕背伸功能的影响。方法 将36例脑卒中偏瘫患者随机分为治疗组和对照组,每组18例。两组药物治疗相同,对照组进行常规康复治疗,治疗组在常规康复治疗基础上加肌电生物反馈技术进行治疗。观察两组治疗前后腕背伸时主动关节活动范围(AROM),腕背伸时肌肉最大收缩时肌电(EMG)阈值。 结果 3个疗程后治疗组患者腕关节的AROM、EMG阈值均优于对照组(P<0.001)。 结论 肌电生物反馈治疗有助于明显改善偏瘫患者腕背伸功能。【Abstract】 Objective To explore the effect of the electromyographic biofeedback therapy on the extension of wrist joint of the hemiplegic patients after stroke. Methods Thirtysix hemiplegic patients were included and were divided into two groups randomly, including a treatment group and a control group. They were treated with the same drugs and the routine rehabilitation therapy while the patients in the treatment group still received the electromyographic biofeedback therapy additionally. Results After three courses of treatment, the patients in the treatment group had better active range of movement (AROM) of extension of wrist joint and also higher electromyographic (EMG) threshold of maximum contraction of muscle than the patients in the control group (Plt;0.001). Conclusion The electromyographic biofeedback therapy has good effect on improving the function of the wrist of hemiplegic patients after stroke.

    Release date:2016-09-08 09:45 Export PDF Favorites Scan
  • 缺血性卒中后癫痫动物模型的研究进展

    卒中后癫痫(Post-stroke epilepsy,PSE)是指继发于脑卒中的癫痫发作且既往无癫痫发作史,其病因包括出血性脑卒中和缺血性脑卒中。虽然缺血性 PSE 的发生率低于出血性脑卒中,但由于缺血性卒中患病率远高于出血性脑卒中,从而缺血性 PSE 患者也多于出血性 PSE 患者。作为脑卒中的常见并发症,卒中后早期癫痫发作会加重脑组织损伤,直接影响患者预后。为了研究缺血性 PSE 的发病机制,制定合理的治疗方案,构建了各种动物模型。文章就缺血性 PSE 动物模型研究进展进行综述。

    Release date:2020-09-04 03:06 Export PDF Favorites Scan
  • Evidence-based Drug Selection for Ischaemic Stroke

    Release date:2016-09-07 02:27 Export PDF Favorites Scan
  • Effectiveness of Psychological Intervention on Post-stoke Depression: A Systematic Review

    Objective To assess the effectiveness of psychological intervention on post-stoke depression. Methods Such databases as the JBI Database of Systematic Review (1980 to June, 2010), The Cochrane Library (1980 to June, 2010), PubMed (1966 to 2010), CINAHL(1982 to May, 2000), CBM (1978 to 2010), and CNKI (1979 to 2010) were searched to collect randomized controlled trials (RCTs). In accordance with the predefined inclusion and exclusion criteria, the quality of included studies was evaluated, and then meta-analyses were performed by using RevMan 5.0 software. Results A total of 33 RCTs were included. The results of meta-analyses showed: (1) Compared with the control group, the short-term effect of psychological intervention was more effective in decreasing depression score. The subgroup analysis showed that the intervention effects at the time of four weeks, six weeks, eight weeks, and 12 weeks were better than those of the control group. (2) The long-term effect of psychological intervention was more effective in decreasing depression score. The subgroup analyses showed that the intervention effects at the interval of eight weeks, 24 weeks, and 48 weeks were better than those of the control group. (3) The combined or single application of either cognitive-behavioral psychotherapy or supportive psychotherapy was more effective in decreasing depression score than the control group. However, there was no significant difference between the general psychological treatment group and the control group. (4) The subgroup analyses showed that the different qualities of the included studies were more effective than those of the control group. Conclusion Various psychological intervention is effective in decreasing the patient’s depression score, and cognitive-behavioral therapy and supportive psychotherapy, especially, can significantly improve the depression state and promote recovery.

    Release date:2016-09-07 11:06 Export PDF Favorites Scan
  • 甲钴胺联合黛力新治疗丘脑痛的临床观察

    【摘要】 目的 观察甲钴胺(商品名:弥可保)联合氟哌噻吨+美利曲辛(商品名:黛力新)治疗丘脑痛的临床疗效。 方法 将58例丘脑痛患者随机分为两组,治疗组采用甲钴胺联合黛力新治疗(n=30);对照组单独应用黛力新治疗(n=28)。以视觉模拟评分法(VAS) 和临床治愈率作为疗效评估指标。结果 甲钴胺联合黛力新治疗组VAS 评分治疗前后分别为7.39±1.32,4.28±0.79,差异有统计学意义(t=3.97,Plt;0.001);黛力新组治疗前后分别为7.21±1.23,6.78±1.31,差异无统计学意义(t=0.48,Pgt;0.05)。联合治疗组临床治愈19例,总有效率63.3%;对照组临床治愈8 例,总有效率28.6%,两组比较差异有统计学意义(χ2=20.92,Plt;0.01)。结论 甲钴胺、黛力新联用治疗丘脑痛的疗效优于黛力新单药治疗。

    Release date:2016-09-08 09:45 Export PDF Favorites Scan
  • Qualitative study on falling experience and coping style of stroke home patients: a Meta synthesis

    Objective To integrate the falling experience and coping styles of stroke home patients with falls through Meta synthesis, summarize existing problems based on the integration results, and propose suggestions. Methods We searched databases including PubMed, Medline, Embase, Web of Science, etc., from database establishment to January 2023, to collect qualitative studies on stroke patients’ falling experience at home. The quality of included studies was evaluated by “JBI Australian Evidence-based Health Care Centre (2008) Qualitative Research Quality Assessment Criteria”. The results were integrated by integrating methods. Results A total of 6 references were included, and 18 clear research results were extracted. Similar results were summarized and combined to form 6 new categories, and integrated into 3 main themes. The integration results showed that stroke patients with falls had severe psychological problems, poor coping styles, and unmet needs for fall prevention, resulting in reduced social participation and exercise. Conclusions It is necessary to improve the content of fall assessment and provide corresponding fall prevention health education based on the assessment results. It helps stroke patients and caregivers at home to establish correct coping strategies, thereby avoiding the occurrence of falls.

    Release date:2023-05-23 03:05 Export PDF Favorites Scan
  • Correlation analysis and predictive value of stress hyperglycemia ratio for clinical prognosis of acute ischemic stroke

    Objective To investigate the correlation between stress hyperglycemia ratio (SHR) and acute ischemic stroke (AIS) 1-year prognosis, to provide more clinical basis to improve the prognosis of AIS patients and to target and control the influencing factors. MethodsThe patients with AIS diagnosed for the first time and received treatment at the Shijiazhuang Fifth Hospital between May 2019 and January 2022 were retrospectively and continuously included. According to the Modified Rankin Scale score 1-year after the onset of the disease, the patients were divided into a good prognosis group and a poor prognosis group. Also the patients were divided into 2 groups based on the median of SHR. The correlation between SHR and stress blood glucose was analyzed, and the factors affecting the prognosis of AIS patients were identified. The predictive value of SHR and stress blood glucose on the prognosis of AIS patients was compared using receiver operating characteristic. Results A total of 206 patients were included. Among them, there were 125 cases (60.7%) in the good prognosis group and 81 cases (39.3%) in the poor prognosis group. The median SHR (lower quartile, upper quartile) is 1.20 (1.08, 1.33). There were statistically significant differences between the two groups in the scores of the National Institutes of Health Stroke Scale, diabetes history, hypertension history, low-density lipoprotein cholesterol, stress blood glucose, age, SHR and SHR classification (P<0.05). There was no statistically significant difference in the other indicators compared between the two groups (P>0.05). Stress blood glucose was positively correlated with SHR (7.95±1.78 vs. 1.21±0.19; r=0.294, P<0.001). Multivariate logistic analysis showed that stress blood glucose and SHR were independent factors influencing the 1-year prognosis of AIS patients (P<0.05), and the interaction between SHR and diabetes was not significant (P>0.05) After adjusting for confounding factors, the area under the receiver operating characteristic curve of SHR for the prognosis of AIS patients was higher than that of stress blood glucose [0.682 (0.614, 0.745) vs .0.585 (0.515, 0.653); Z=2.042, P=0.041]. Conclusions SHR and stress blood glucose are independent risk factors for 1-year prognosis in AIS patients. However, SHR has a better predictive value for 1-year prognosis in AIS patients than stress blood glucose. Whether the patient has diabetes or not, the impact of SHR on the prognosis of AIS patients is consistent.

    Release date:2024-02-29 12:02 Export PDF Favorites Scan
  • Research progress on mechanical perturbation in stroke rehabilitation

    Sensorimotor disorder can be easily caused by stroke, and there are many targeted movement rehabilitation therapies. With the development of rehabilitation robot technology, robot-assisted therapy combined with mechanical perturbations has become a more effective motor rehabilitation therapy. In this paper, the definition of mechanical perturbation and its physiological mechanism in stroke rehabilitation are introduced, the research progress on mechanical perturbation in the field of stroke rehabilitation therapy is mainly discussed, the application of mechanical perturbation in motor control, postural response and sensory evaluation of stroke rehabilitation is summarized, and the future development direction of mechanical perturbation rehabilitation therapy is also prospected.

    Release date:2023-02-24 06:14 Export PDF Favorites Scan
  • Analysis of clinical studies on puerarin for ischemic stroke

    Objective To investigate the current situation of clinical studies on puerarin for ischemic stroke and the reliability of these evidence. Methods By electronic searching and handsearching, we collected all the published clinical study reports on puerarin for ischemic stroke and assessed all the included reports according to clinical epidemiologic standard. Results 35 RCTs, 22 non-randomized controlled trials and 17 case serials studies were included and analysed. Conclusions Current quality of clinical studies of puerarin for ischemic stroke is not good enough to provide reliable evidence.

    Release date:2016-09-07 02:29 Export PDF Favorites Scan
34 pages Previous 1 2 3 ... 34 Next

Format

Content